22 studies found for:    N08C9
Show Display Options
Rank Status Study
1 Active, not recruiting Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea;   Gastrointestinal Complications;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: sulfasalazine;   Other: placebo
2 Recruiting Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
Condition: Depression
Interventions: Device: C-ECT;   Drug: PHARMACOTHERAPY
3 Completed
Has Results
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: FDG-PET;   Drug: Pemetrexed;   Drug: Sirolimus;   Dietary Supplement: Vitamin B12;   Dietary Supplement: Folic acid tablets;   Drug: Dexamethasone tablets
4 Completed Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59
Condition: Influenza
Interventions: Biological: MF-59;   Biological: A/Anhui/05;   Drug: Placebo
5 Recruiting Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases
Conditions: Brain Metastasis;   Cancer
Intervention:
6 Enrolling by invitation A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
Condition: Hepatitis C, Chronic
Intervention:
7 Completed Malaria Vaccine for Children in Mali
Conditions: Malaria;   Malaria Infection
Intervention: Drug: AMA1-C1/Alhydrogel plus CPG 7909
8 Enrolling by invitation Gilead Sustained Virologic Response (SVR) Registry
Condition: Hepatitis C, Chronic
Intervention:
9 Completed
Has Results
Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers
Condition: Meningococcal Infections
Interventions: Biological: MenACWY-CRM + MMRV;   Biological: MMRV;   Biological: MenACWY-CRM
10 Recruiting Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Condition: Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Other: Placebo;   Drug: Effective statin therapy
11 Terminated GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
Condition: Lung Cancer, Non-Small Cell
Interventions: Biological: GSK1572932A Antigen-Specific Cancer Immunotherapeutic;   Biological: Placebo Control
12 Recruiting Peri-operative Azithromycin to Improve Early Allograft Function and Outcome After Lung Transplantation
Condition: Disorder Related to Lung Transplantation
Interventions: Drug: Azithromycin;   Drug: Ora-Plus
13 Active, not recruiting
Has Results
Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer
Condition: Breast Cancer
Interventions: Drug: PD 0332991;   Drug: letrozole
14 Completed A Multicenter Trial To Evaluate Oral Retrovir in the Treatment of Children With Symptomatic HIV Infection
Condition: HIV Infections
Intervention: Drug: Zidovudine
15 Completed Dose Escalation Study of SQ109 in Healthy Adult Volunteers
Condition: TB Multi-drug Resistant
Interventions: Drug: SQ109;   Drug: Placebo
16 Completed
Has Results
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
Condition: Rotavirus Infection
Interventions: Biological: Rotarix®;   Biological: RotaTeq®
17 Recruiting Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Condition: Indolent Non-Hodgkin's Lymphomas
Interventions: Drug: Idelalisib;   Drug: Rituximab;   Drug: Bendamustine;   Drug: Placebo to match idelalisib
18 Recruiting Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Condition: Indolent Non-Hodgkin's Lymphomas
Interventions: Drug: Idelalisib;   Drug: Rituximab;   Drug: Placebo to match idelalisib
19 Completed
Has Results
Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Interventions: Drug: Lactobacillus plantarum 299v;   Drug: Placebo comparator;   Other: Run in period;   Other: Wash - out period
20 Recruiting Immunogenicity of Off-Schedule Dosing of HPV Vaccine
Condition: Papilloma Viral Infection
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results    Last Page
Indicates status has not been verified in more than two years